EMI Holding Inactive 10-Q2011 Q3 Quarterly report

Filed: 14 Nov 11, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: absolute, abundant, acknowledged, Addendum, admit, Alternatively, AminioPure, Amo, Andrew, bank, batch, biologic, Black, cardiac, ceased, classification, confirmation, cornea, corneal, criteria, Cust, customer, damaged, deadline, deduction, Del, Delfan, deliver, Destination, destroyed, discharged, discontinued, earned, eighty, Eiko, Eleven, EMEA, error, exact, expiry, explored, extension, extraordinary, Family, FBO, FINRA, FOB, foreign, fraction, freight, Fujisawa, guaranteed, handling, heart, Hideki, history, hormone, human, hundred, inclusive, intent, introduction, issuable, Jun, label, labeled, landlord, Letter, lieu, line, LOI, memo, Min, missing, mutual, Nakamura, nominal, obligated, occurrence, offeree, outlined, personally, printed, produced, raw, recalled, reception, recombinant, reduction, repaid, Restated, run, Saito, satisfactory, shipped, Shitabata, single, small, Subsequent, subsequently, Suh, Suite, Sumiko, Technoble, Teranishi, test, thousand, translation, Trust, Uehara, unreasonable, unsatisfactory, warrantholder, withdrawn, Wood, writing, Yumi, Yung

Removed: large

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

EMI Holding similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Emmaus Life Sciences, Inc. 10-Q

Exhibit 32.1

Certification of Chief Executive Officer and Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the quarterly report of Emmaus Life Sciences, Inc. (the “Company”) on Form 10-Q for the quarter ending September 30, 2011, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), each of the undersigned, in the capacities and on the date indicated below, hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:

	(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

	(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ Yutaka Niihara

Yutaka Niihara, M.D., MPH
President and Chief Executive Officer
(Principal Executive Officer)
November 14, 2011

/s/ Yasushi Nagasaki

Yasushi Nagasaki
Chief Financial Officer
(Principal Financial and Accounting Officer)
November 14, 2011